MCM
GSK icon

Moore Capital Management’s GSK GSK Stock Holding History

Moore Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100,000
Closed -$3.63M – 485
2023
Q3 		$3.63M Hold
100,000
– – 0.07% 198
2023
Q2 		$3.56M Buy
+100,000
New +$3.59M 0.06% 206

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Moore Capital Management's GSK Position: Q4 2023 in Review

Moore Capital Management sold out of GSK (GSK) in Q4 2023, closing a stake of 87,087 shares — an estimated $3.16M sold.

Moore Capital Management first reported a position in GSK in Q1 2014 and held it in 3 quarters. The position peaked at $4.01M in Q1 2014. 895 funds tracked by Wall St. Rank hold GSK as of Q4 2023.

  • Moore Capital Management reported no remaining GSK position as of Q4 2023 after selling out during the quarter.
  • Moore Capital Management sold 87,087 GSK shares in Q4 2023, an estimated $3.16M.
  • Moore Capital Management first reported a position in GSK in Q1 2014 and held it in 3 quarters.
  • Moore Capital Management's GSK position peaked at $4.01M in Q1 2014.
  • 895 funds tracked by Wall St. Rank held GSK as of Q4 2023.

Based on Moore Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.